Compare Crown Castle International Corp (CCI) vs Quest Diagnostics Inc (DGX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crown Castle International Corp vs Quest Diagnostics Inc — how do they compare? Crown Castle International Corp trades at $73.76 (market cap $31.33B), while Quest Diagnostics Inc trades at $237.51 (market cap $26.21B). The key difference: Crown Castle International Corp is the larger of the two by market cap, and Crown Castle International Corp pays the higher dividend (5.77%). Which is the better fit depends on your goals.
| CCI | DGX | |
|---|---|---|
Market Cap | $31.33B | $26.21B |
Sector | Real Estate | Health |
52-Week High | $103.79 | $238.50 |
52-Week Low | $73.61 | $173.49 |
Enterprise Value | $53.69B | $31.97B |
Dividend Yield | 5.77% | 1.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Crown Castle (CCI) trades at $73.98, near 52-week lows, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 AFFO of $1.13 per share, beating estimates, and raised full-year guidance amid its transition to a pure-play U.S. tower operator. Revenue declined to $4.26B in 2025 but profitability improved with 20.72% net margin. Analyst consensus remains divided with 50% buy ratings and $95.29 price target suggesting 29% upside.
The stock presents a value opportunity with discounted valuation and 5.5% dividend yield, but faces headwinds from high debt levels (77.21% debt-to-asset ratio) and competitive pressure in the tower REIT sector. Recent institutional selling and technical weakness indicate near-term caution despite long-term growth potential from wireless infrastructure demand.
Quest Diagnostics (DGX) trades at $237.99, up 0.15% on the day, near its 52-week high. The stock shows strong momentum with consecutive earnings beats in 2026, including Q2 EPS of $3.12 versus $2.82 expected. Revenue growth accelerated to $11.04 billion in 2025, with net income margin at 9.19%. Technical indicators signal a bullish trend, while analyst consensus is a $249.50 price target. Recent news highlights AI integration and raised 2026 outlook amid robust testing demand.
The outlook for DGX is positive, driven by earnings momentum, strategic partnerships, and healthcare demand. Investment opportunity lies in sustained growth and dividend yield, but risks include margin pressure from lower-margin deals and high debt levels. Valuation at a P/E of 25.21 requires continued execution to justify upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →
